Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Deregulation of microRNA-181c in cerebrospinal fluid of patients with clinically isolated syndrome is associated with early conversion to relapsing-remitting multiple sclerosis.
The Role of 3-O-Sulfogalactosylceramide, Sulfatide, in the Lateral Organization of Myelin Membrane.
Cambridge Healthtech Institute's Third Annual Anti-inflammatories: small Molecules Meeting, April 17(th) - 18(th) 2012, San Diego, USA.
ENDOCANNABINOID SYSTEM: A multi-facet therapeutic target.
Adherence to Long-Term Interferon Beta-1b Injection Therapy in Patients with Multiple Sclerosis Using an Electronic Diary.
Ultra-high-field MR imaging in multiple sclerosis.
Two demyelinating diseases in the brain of a single patient, PML and MS: how to minimize 'one' while treating the 'other'.
Promoting Remyelination in Multiple Sclerosis-Recent Advances.
Phagocytosis of Microglia in the Central Nervous System Diseases.
Sex-biased chromatin and regulatory cross-talk between sex chromosomes, autosomes, and mitochondria.
Validity of Minimal Clinically Important Difference Values for the Multiple Sclerosis Walking Scale-12?
Randomised multicentre trial on safety and efficacy of rivastigmine in cognitively impaired multiple sclerosis patients.
Clinical association of intrathecal and mirrored oligoclonal bands in paediatric neurology.
Cognitive Impairment Occurs in Children and Adolescents With Multiple Sclerosis: Results From a United States Network.
An exploration of impaired walking dynamics and fatigue in Multiple Sclerosis.
The role of KIR2DS1 in multiple sclerosis: KIR in Portuguese MS patients.
Mean upper cervical cord area (MUCCA) measurement in long-standing multiple sclerosis: Relation to brain findings and clinical disability.
Osmotic Demyelination Syndrome as the Initial Manifestation of a Hyperosmolar Hyperglycemic State.
Natural Killer Cell Subsets in Cerebrospinal Fluid of Patients with Multiple Sclerosis.
Incidence of Multiple Sclerosis and Related Disorders in Asian Populations of British Columbia.
Coordinated Gene Expression of Neuroinflammatory and Cell Signaling Markers in Dorsolateral Prefrontal Cortex during Human Brain Development and Aging.
Role of Glycine N-methyltransferase in The Regulation of T Cell Responses in Experimental Autoimmune Encephalomyelitis.
Quantitative sensory and motor measures detect change over time and correlate with walking speed in individuals with multiple sclerosis.
Astrocyte response to IFN-γ limits IL-6-mediated microglia activation and progressive autoimmune encephalomyelitis.
External memory aids for memory problems in people with multiple sclerosis: A systematic review.
Pages
« first
‹ previous
…
491
492
493
494
495
496
497
498
499
…
next ›
last »